are glp 1 compounds going away Our first topic in The Pharmacy Gray Zone series covers GLP-1 agonists. This class continues to reshape healthcare and highlight some of the most complex challenges we face across pharmacy practice. From The GLP-1 drug shortage is

In addition, NE is a critical regulator of hippocampal synaptic plasticity, and its release can modulate long-lasting changes in synaptic efficacy on the basis of LTP and LTD, thereby contributing to memory consolidation and storage (Katsuki et al., 1997

Thermo Fisher Scientific), and CRISPRMAX Cas9 Plus Reagent (CMAX00015

More Medications Mean More Choice Now that there are multiple GLP-1 drugs for obesity, including more than one pill for people with an aversion to needles, patients can really make a choice based on whats most convenient and affordable and achieve meaningful weight loss with any option they select, Jay says

developed a smaller enzyme called BioID2 with a molecular weight of 27 kDa, derived from Aquifex aeolicus [16]